InsidersTradesSigma
Follow the 온코닉테라퓨틱스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 온코닉테라퓨틱스 has recorded 6 reports. Market capitalisation: €504.5bn. The latest transaction was reported on 12 June 2026 (Sale). Among the most active insiders: 김정훈. The full history is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€587,929
3 ops.
Buy Volume
€257,169
2 ops.
Sell Volume
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,835 of 29,062 companies
63.0
score / 100
Value31
Quality95
FCF yld1.4%
Earn yld2.0%
EV/EBITDA56.7x
ROE29%
Gross mgn100%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 June 2026
Declarations6 total
6 of 6 declarations
关于 온코닉테라퓨틱스
Onconic Therapeutics 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发针对严重疾病的创新疗法。